| Literature DB >> 23566198 |
Alex Stewart1, Joseph S Harrison, Lauren K Regula, Jonathan R Lai.
Abstract
BACKGROUND: Analysis of factors contributing to high affinity antibody-protein interactions provides insight into natural antibody evolution, and guides the design of antibodies with new or enhanced function. We previously studied the interaction between antibody D5 and its target, a designed protein based on HIV-1 gp41 known as 5-Helix, as a model system [Da Silva, G. F.; Harrison, J. S.; Lai, J. R., Biochemistry, 2010, 49, 5464-5472]. Antibody D5 represents an interesting case study because it is derived from the VH1-69 germline segment; this germline segment is characterized by a hydrophobic second heavy chain complementarity determining region (HCDR2) that constitutes the major functional paratope in D5 and several antibodies derived from the same progenitor.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23566198 PMCID: PMC3626704 DOI: 10.1186/1471-2091-14-9
Source DB: PubMed Journal: BMC Biochem ISSN: 1471-2091 Impact factor: 4.059
Figure 1Structure of the D5-5-Helix interaction and similarities to CR6261. (a) Crystal structure of the D5-5-Helix complex reported by Luftig et al. (ref. 6, PDB ID 2CMR). The D5 light chain is colored in red, the D5 heavy chain in blue, and 5-Helix in yellow; side chains of residues involved in the interface are shown in stick. The critical HCDR2 is boxed. (b) Similarity of interactions involving HCDR2 in D5 and CR6261 (ref. 11, PDB ID 3GBN). In both antibody-antigen complexes, F54 of HCDR2 (a germline-encoded residue) inserts into a hydrophobic cleft on the antigen (here, shown in gray). The amino acid sequence of HCDR1 and HCDR2 regions from VH1-69, D5, and CR6261 are also shown. (c) Cross-reactivity analysis of phage clones displaying the bivalent scFv (biv-scFv) of D5 and CR6261. Phage titers were ~ 1012 infectious units/mL for both clones.
Library design
| | | | ||||
|---|---|---|---|---|---|---|
| D5-Lib-I | A/D/H/P/S/Y | A/D/H/P/S/Y | A/D/H/P/S/Y | A/D/H/P/S/Y | 8 x 1017 | 3 x 109 |
| D5-Lib-II | TailoredC | TailoredC | TailoredC | A/C/D/E/G/K/N/R/S/T/Y/W | 8 x 1019 | 3 x 109 |
A Amino substitutions encoded by limited diversity codon sets. For LCDRs 1 – 3: BMT (D5-Lib-I), or tailored codon sets listed in Table 2 (D5-Lib-II); for HCDR3 in all libraries: DVK. Nucleotide degeneracies: M = A/C, B = C/G/T, D = A/G/T, V = A/C/G, K = G/T.
B In LCDR1 and HCDR3, the library synthesis was performed in such a manner to allow the D5 WT sequence as an alternative to the library sequences.
C Tailored diversity codon sets used as shown in Table 2.
Library design
| | ||||
| E27 | Low | E(3)/Q(13)/S(2) | Not varied | E (17%) |
| G28 | Mid | D*(5)/G(2)/N(1)/Q(1)/S(8)/Y*(1) | D/N/G/S (88%) | |
| Y30 | Mid | G(3)/R(1)/S*(10)/Y*(2)/V(1) | C/D/F/G/H/I/N/L/R/S/V/Y (100%) | |
| H31 | Mid | H(4)/N*(5)/S(7)/T(2) | C/D/F/G/H/I/N/L/R/S/V/Y (61%) | |
| W32 | High | A(2)/D(1)/F(1)/G(1)/M(1)/N(2)/S(1)/W*(2)/Y*(6)/- (1) | C/D/F/G/H/I/N/L/R/S/V/Y (56%) | |
| | ||||
| Y49 | High | Y*(18) | S/Y (100%) | |
| K50 | High | A(2)/D(1)/G(5)/K*(3)/L(2)/S(2)/Y*(3) | C/H/N/R/S/Y (28%) | |
| S52 | Low | S(17)/T(1) | S/Y (94%) | |
| S53 | Mid | F*(2)/N(3)/R*(3)/S(6)/T(3)/Y(1) | C/H/N/R/S/Y (73%) | |
| A55 | Low | A(9)/F(1)/H(3)/K(1)/P(1)/Q(1)/Y(2) | Not varied | A (50%) |
| | ||||
| Y91 | High | F(1)/G(3)/H(2)/R*(1)/S(3)/W*(2)/Y*(6) | C/H/N/R/S/Y (67%) | |
| S92 | High | A(1)/D*(1)/G(4)/L(1)/N*(3)/S*(4)/T(1)/W(1)/Y(2) | A/D/S/Y (44%) | |
| N93 | High | A(1)/D(1)/G(4)/H(1)/N*(5)/Q(1)/S*(1)/T(4) | A/D/G/N/S/T (89%) | |
| Y94 | Mid | L(3)/N(2)/S*(5)/T(3)/V(1)/W(2)/Y*(1)/- (1) | A/D/N/S/T/Y (61%) | |
| P95 | Mid | L(2)/P*(16) | Not varied | P (89%) |
| L96 | High | F*(2)/I(1)/L*(1)/P(5)/R(1)/S(1)/W(4)/Y(3) | C/F/H/L/R/Y (39%) | |
| T97 | Low | R(1)/T(17) | Not varied | T (94%) |
A A ‘contact score’ for each position was assigned based on inspection of the antibody-antigen crystal structures in Additional file 1: Table S1. The involvement of each residue side chain was scored based on the buried surface area upon complex formation; positions that constituted a major element of the structural paratope in multiple antibodies were ranked ‘high’.
B The amino acid identities and their observed frequency are listed. Residues that were heavily involved in the interaction in at least one antibody-antigen complex are indicated with an asterix. In some cases, loops lengths were shorter than D5; these are indicated by a ‘-‘at some positions.
C Nucleotide degeneracies: D = A/G/T, K = G/T, H = A/C/T, M = A/C, N = A/G/C/T, R = A/G, V = A/G/C, Y = C/T.
D ‘Coverage’ indicates the percentage of the naturally observed diversity that is encoded in the degenerate codon.
Sequences and phage ELISA profiles of selected clones
| | | | |||||||
|---|---|---|---|---|---|---|---|---|---|
| | | | | | |||||
| D5-Lib-I | 6G10 | 0.4/0.1 (5) | 0.4/0.2 (3) | 0.4/0.1 (3) | 1.0 | ||||
| | 6G12 | 0.6/0.1 (6) | 0.6/0.3 (2) | 0.6/0.2 (3) | 0.8 | ||||
| | 6D9 | 0.4/0.1 (5) | 0.4/0.2 (3) | 0.4/0.1 (3) | 0.7 | ||||
| | 6B11 | 0.4/0.1 (5) | 0.4/0.2 (2) | 0.4/0.2 (2) | 1.0 | ||||
| D5-Lib-II | 25B8 | 2.9/0.1 (22) | 2.9/0.1 (21) | 2.9/0.2 (12) | 0.2 | ||||
| | 25C10 | 3.2/0.1 (34) | 3.2/0.1 (33) | 3.2/0.2 (18) | 0.1 | ||||
| | 25D8 | 3.2/0.1 (30) | 3.2/0.1 (22) | 3.2/0.2 (18) | 0.2 | ||||
| | 25A10 | 3.2/0.1 (23) | 3.2/0.1 (22) | 3.2/0.2 (14) | 0.1 | ||||
| | 25D9 | 3.0/0.1 (23) | 3.0/0.1 (24) | 3.0/0.2 (17) | 0.2 | ||||
| | 25G8 | 2.1/0.1 (24) | 2.1/0.1 (25) | 2.1/0.1 (16) | 0.1 | ||||
| | 25C6 | 1.8/0.1 (25) | 1.8/0.1 (20) | 1.8/0.1 (15) | 0.2 | ||||
| | 25C12 | 2.2/0.1 (23) | 2.2/0.1 (18) | 2.2/0.2 (10) | 0.3 | ||||
| | 25D6 | 1.6/0.1 (21) | 1.6/0.1 (19) | 1.6/0.1 (14) | 0.1 | ||||
| | 25D3 | 1.6/0.1 (20) | 1.6/0.1 (17) | 1.6/0.2 (10) | 0.1 | ||||
| | 25F1 | 2.3/0.1 (24) | 2.3/0.1 (20) | 2.3/0.1 (15) | 0.1 | ||||
| | 25B6 | 1.4/0.1 (16) | 1.4/0.1 (15) | 1.4/0.1 (11) | 0.1 | ||||
| | 25F10 | 1.7/0.1 (22) | 1.7/0.1 (22) | 1.7/0.1 (13) | 0.1 | ||||
| | 25A12 | 3.2/0.1 (27) | 3.2/0.2 (20) | 3.2/0.3 (12) | 0.1 | ||||
| | 25A5 | 3.5/0.1 (24) | 3.5/0.1 (24) | 3.5/0.2 (15) | 0.1 | ||||
| | 16F6 | 3.0/0.2 (13) | 3.0/0.3 (11) | 3.0/0.7 (4) | 0.8 | ||||
| | 25C5 | 0.7/0.1 (10) | 0.7/0.1 (8) | 0.7/0.1 (6) | 0.5 | ||||
| | 16D10 | 3.0/0.1 (20) | 3.0/0.2 (20) | 3.0/0.5 (7) | 0.7 | ||||
| | 16G6 | 2.3/0.2 (14) | 2.3/0.2 (12) | 2.3/0.3 (7) | 0.3 | ||||
| | 16B7 | 3.0/0.1 (33) | 3.0/0.1 (22) | 3.0/0.5 (6) | 0.6 | ||||
| | 16E12 | 3.1/0.4 (9) | 3.1/0.3 (12) | 3.1/0.7 (5) | 0.1 | ||||
| | 25F12 | 2.7/0.1 (27) | 2.7/0.1 (23) | 2.7/0.2 (12) | 0.2 | ||||
| | 25B4 | 2.9/0.1 (29) | 2.9/0.1 (31) | 2.9/0.1 (22) | 0.1 | ||||
| | 16E8 | 3.0/0.1 (21) | 3.0/0.2 (12) | 3.0/0.3 (9) | 0.4 | ||||
| | 25E1 | 3.0/0.1 (32) | 3.0/0.1 (28) | 3.0/0.2 (20) | 0.1 | ||||
| | 25A6 | 3.1/0.2 (20) | 3.1/0.1 (25) | 3.1/0.2 (16) | 0.1 | ||||
| | 16E3 | 3.0/0.3 (11) | 3.0/0.4 (8) | 3.0/0.6 (5) | 0.7 | ||||
| | 2H10 | 1.9/0.1 (15) | 1.9/0.1 (19) | 1.9/0.2 (10) | 0.1 | ||||
| | 25C4 | 2.5/0.1 (32) | 2.5/0.1 (26) | 2.5/0.1 (19) | 0.1 | ||||
| 16F5 | 3.0/0.2 (19) | 3.0/0.2 (12) | 3.0/0.3 (11) | 0.2 | |||||
A In cases where selection of the entire CDR was observed (for HCDR3 and LCDR3), the sequence is italicized. Positions that were not randomized are underlined.
B For each clone, the raw ELISA signal (OD450) is shown against both 5-Helix and control proteins BSA, lactoferrin (LF), or keyhole limpet hemocyanin (KLH). The ratio of ELISA signals for 5-Helix over each of the three control proteins is shown in parentheses.
C The reduction in ELISA signal observed upon preincubation with free 5-Helix (500 nM, D5-Lib-I; 40 nM, D5-Lib-II) as a fraction of the signal observed in the absence of the competitor.
D Kabat numbering for the first residue of each CDR is shown for D5 WT.
Figure 25-Helix and 6-Helix-Fd design and competitive ELISA. Design of 5-Helix and 6-Helix-Fd (a), and competitive ELISA with D5 scFv (b, phage-bound bivalent scFv; c, purified monovalent scFv).
Apparent affinities of clones from D5-Lib-II selection against 5-Helix
| | ||||
|---|---|---|---|---|
| D5 WT | 0.1 (0.07-0.1) | 11 (8–15) | 7.3 (5.3-10) | 290 |
| 25B8 | 3.1 (1.8-5.3) | ~100 | NDB | NDB |
| 25C10 | 1.8 (1.3-2.7) | 28 (21–37) | 56 (40–79) | |
| 25D8 | 5.8 (4.2-7.5) | ~3000 | NDB | NDB |
| 25A10 | 1.6 (1.3-2.0) | 260 (150–450) | 5.4 (3.8-7.7) | ~500 |
| 25D9 | 1.7 (1.4-2.1) | 230 (150–360) | NDB | NDB |
| 25G8 | 7.2 (4.2-12.3) | 300 (120–750) | NDB | NDB |
| 25C6 | 32 (24–44) | ~1000 | NDB | NDB |
| 25C12 | 100 (31–300) | ~1000 | NDB | NDB |
| 25D6 | 0.5 (0.3-0.8) | ~80 | NDB | NDB |
| 25D3 | 17 (9.9-30) | 170 (70–390) | NDB | NDB |
| 25F1 | 0.9 (0.7-1.2) | 40 (20–79) | NDB | NDB |
| 25B6 | 0.3 (0.2-0.4) | 23 (15–36) | 0.6 (0.3-1.0) | 94 (56–160) |
| 25F10 | 0.2 (0.2-0.3) | 22 (16–30) | NDB | NDB |
| 25A12 | 2.2 (1.2-4.0) | 220 (70–670) | 34 (23–52) | 280 (120–640) |
A 95% Confidence intervals from data fitting are shown in parentheses.
B ND, not determined.
CNC, no convergence observed upon data fitting, suggesting weak or insignificant binding.
Apparent affinities of clones from D5-Lib-II Selection against 5-Helix
| | | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | |||||||||||||||||||
| | - | - | - | | - | - | - | - | - | - | |||||||||
| | - | - | - | | - | - | - | - | - | - | |||||||||
| - | |||||||||||||||||||
A For each position, the percentage of the population of analyzed clones is shown for the 1st, 2nd, 3rd, and 4th most frequently observed residue from the 5-Helix selection. The WT D5 residue is indicated prior to the position number in the first column and the “hotspot” positions identified by Da Silva et al. are marked by asterisk. If two of the amino acids exhibit the same frequency, the one with the higher Function/Display ratioC will rank in a higher order. In cases where additional substitutions were permitted and observed, these were binned into a 5th category labeled ‘other’. At positions 49 and 52, only two residues (Tyr and Ser) were permitted. The data shown here were compiled from 178 sequences from the 5-Helix selection and 169 sequences from the display selection.
B Amino acids shown in the four most frequently observed at each position among library members that are identical to WT D5 are shown in gray italic font. For positions that the WT residue was not encoded in the library due to codon degeneracy, amino acids that have the closest physiochemical properties to the WT that is among the four most frequent residues are in black italic fonts.
C Ratio of percent frequency observed from functional (5-Helix) selection and percent frequency observed from display (anti-FLAG) selection.
Figure 3Optimized complementarity in the 25B6-5Helix interaction revealed by modeling. (a) Structural model of 25B6 complexed with 5-Helix (in cartoon) is superimposed onto the crystal structure of D5-5-Helix complex (PDB ID 2CMR). 25B6 is colored in deep olive, D5 in cyan, and 5-Helix in orange. Side chains of residues participating in the interaction are shown as stick; for 5-Helix, the side chains are colored teal in the D5-5-Helix model, and orange in the 25B6-5-Helix model. Electrostatic potential surface of 5-Helix from the 25B6 modeling is shown as well. (b) Potential of R30 in 25B6 to contact several residues on the periphery of the 5-Helix. (c) Potential interaction of E157 (5-Helix) with R50 and R53 of 25B6. (d) Potential polar interactions between 25B6 and 5-Helix mediated through D92 and D93 and a water molecule.